Second Line Capital’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$242K Sell
1,526
-77
-5% -$11.5K 0.05% 140
2026
Q1
$234K Sell
1,603
-328
-17% -$50.6K 0.04% 157
2025
Q4
$299K Sell
1,931
-9
-0.5% -$1.35K 0.06% 111
2025
Q3
$270K Sell
1,940
-449
-19% -$60.8K 0.06% 122
2025
Q2
$322K Sell
2,389
-85
-3% -$11.5K 0.07% 100
2025
Q1
$361K Sell
2,474
-600
-20% -$87.2K 0.09% 86
2024
Q4
$423K Sell
3,074
-293
-9% -$42.9K 0.11% 70
2024
Q3
$519K Sell
3,367
-216
-6% -$32.7K 0.14% 65
2024
Q2
$522K Sell
3,583
-1,088
-23% -$156K 0.16% 62
2024
Q1
$690K Sell
4,671
-2,134
-31% -$306K 0.22% 54
2023
Q4
$928K Buy
+6,805
New +$885K 0.37% 48

Other funds holding XLV

Second Line Capital's XLV Position: Q2 2026 in Review

Second Line Capital reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 4.8% in Q2 2026, selling an estimated $11.5K and leaving 1,526 shares worth $242K. The position accounts for 0.05% of the portfolio, ranked #140.

Second Line Capital first reported a position in XLV in Q4 2023 and has held it in 11 quarters since. The position peaked at $928K in Q4 2023. 1,852 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • Second Line Capital held 1,526 shares of State Street Health Care Select Sector SPDR ETF worth $242K as of Q2 2026.
  • Second Line Capital sold 77 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $11.5K.
  • State Street Health Care Select Sector SPDR ETF made up 0.05% of Second Line Capital's portfolio in Q2 2026, its #140 holding.
  • Second Line Capital first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2023 and has held it in 11 quarters since.
  • Second Line Capital's State Street Health Care Select Sector SPDR ETF position peaked at $928K in Q4 2023.
  • 1,852 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Second Line Capital's 13F filing for Q2 2026, filed 12 Aug 2026.